Eisler Capital (UK)’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$927K Hold
45,600
﹤0.01% 489
2024
Q2
$1.03M Buy
45,600
+20,000
+78% +$524K 0.01% 439
2024
Q1
$672K Sell
25,600
-238,700
-90% -$6.8M 0.01% 539
2023
Q4
$8.34M Sell
264,300
-48,300
-15% -$1.31M 0.06% 228
2023
Q3
$8.77M Buy
312,600
+17,700
+6% +$608K 0.06% 226
2023
Q2
$10.9M Buy
294,900
+103,700
+54% +$3.17M 0.08% 176
2023
Q1
$5.72M Buy
+191,200
New +$6.3M 0.06% 205

Other funds holding CC

Eisler Capital (UK)'s CC Position: Q3 2024 in Review

Eisler Capital (UK) increased its Chemours (CC) stake by 81% in Q3 2024, buying an estimated $351K and bringing the position to 38,281 shares worth $778K. The position accounts for ﹤0.01% of the portfolio, ranked #508.

Eisler Capital (UK) first reported a position in CC in Q1 2023 and has held it in 6 quarters since. The position peaked at $5.14M in Q3 2023. 421 funds tracked by Wall St. Rank hold CC as of Q3 2024.

  • Eisler Capital (UK) held 38,281 shares of Chemours worth $778K as of Q3 2024.
  • Eisler Capital (UK) bought 17,153 Chemours shares in Q3 2024, an estimated $351K.
  • Chemours made up ﹤0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #508 holding.
  • Eisler Capital (UK) first reported a position in Chemours in Q1 2023 and has held it in 6 quarters since.
  • Eisler Capital (UK)'s Chemours position peaked at $5.14M in Q3 2023.
  • 421 funds tracked by Wall St. Rank held Chemours as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.